REQUEST A DEMO
Total
USD $0.00
Search more companies

Beecham Pharmaceuticals (Pte) Ltd. (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Secondary Activities: All Other Personal Services
Full name: Beecham Pharmaceuticals (Pte) Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Beecham Pharmaceuticals (Pte) Ltd. is an enterprise located in Singapore, with the main office in Singapore. The enterprise currently operates in the Biological Product (except Diagnostic) Manufacturing sector. Beecham Pharmaceuticals (Pte) Ltd. was incorporated on October 10, 1970. It currently has a total number of 42 (estimated) employees. The company’s latest financial report indicates a net sales revenue drop of 23.18% in 2024. Over the same period, its total assets decreased by 0.99%. The enterprise’s net profit margin increased by 3.09% in 2024.

Headquarters
38 Quality Road Singapore
Singapore; Singapore; Postal Code: 618809

Contact Details: Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Outstanding Shares:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Financial Auditors:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Incorporation Date:
October 10, 1970
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Beecham Pharmaceuticals (Pte) Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-23.18%
Total Operating Revenue
-23.18%
Net Profit/Loss for the Period
5.44%
Total Assets
-0.99%
Total Equity
9.47%
Net Profit Margin
3.09%
Return on Equity (ROE)
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?